SKOPJE (N. Macedonia), May 21 (SeeNews) - North Macedonian drug maker Replek [MSE:REPL] said that its consolidated net profit plunged by an annual 35% to 22 million denars ($399,000/358,000 euro) in the first quarter of 2019 as expenses grew quicker than revenue.